培美曲塞+顺铂方案诱导化疗联合同期放化疗对局部晚期非小细胞肺癌的近期疗效及安全性观察

来源 :现代生物医学进展 | 被引量 : 0次 | 上传用户:winyx000
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探究培美曲塞+顺铂方案诱导化疗联合同期放化疗对局部晚期非小细胞肺癌的近期疗效及安全性。方法:收集我院肿瘤科2009年7月到2011年7月住院治疗的局部晚期非鳞癌非小细胞癌患者54例,按照随机数字表法分为研究组和对照组,每组27例,研究组给予培美曲塞+顺铂方案诱导化疗联合同期放化疗,对照组仅给予培美曲塞+顺铂方案化疗联合同期放疗,治疗2个周期,随访2年,对比两组患者的近期疗效及安全性。结果:研究组的近期有效率和控制率分别为55.56%、77.78%,高于对照组的50.33%和59.26%,有效率和控制率差异具有统计学意义(P<0.05)。随访2年,研究组的中位生存期为12.77个月,1年生存率为48.15%,高于对照组中位生存期11.28个月,1年生存率40.74%,但差异无统计学意义(P>0.05),研究组2年生存率为43.46%,高于对照组的25.38%,差异具有统计学意义(P<0.05);研究组白细胞减少以及脱发发生率分别为37.0%、25.9%,低于对照组的81.5%和55.5%,差异具有统计学意义(均P<0.05);研究组中血小板减少、血红蛋白减少、呕吐、肝功能损害、肾功能损耗、皮疹等发生率分别为40.7%、22.2%、59.2%、11.1%、7.4%、14.8%,高于对照组中各不良反应发生率分别为33.3%、18.5%、55.5%、14.8%、11.1%、7.4%,但两组间差异无统计学意义(P>0.05)。结论:培美曲塞+顺铂方案诱导化疗联合同期放化疗对局部晚期非小细胞肺癌治疗效果明显,且不良反应少,可作为临床上晚期非小细胞肺癌化疗一线药物。 Objective: To investigate the short-term efficacy and safety of pemetrexed + cisplatin-induced chemotherapy plus concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. Methods: Totally 54 patients with locally advanced NSCLC who were hospitalized in our hospital from July 2009 to July 2011 were divided into study group and control group according to the random number table method, with 27 cases in each group. The study group was given pemetrexed + cisplatin chemotherapy induction chemotherapy combined with the same period, the control group was given pemetrexed + cisplatin chemotherapy alone with concurrent radiotherapy, the treatment of two cycles, followed up for 2 years, compared the two groups of patients with recent Efficacy and safety. Results: The effective rate and control rate of the study group were 55.56% and 77.78% respectively, higher than that of the control group (50.33% and 59.26%, P <0.05). The follow-up of 2 years, the study group’s median survival was 12.77 months, 1-year survival rate was 48.15%, higher than the median survival time of 11.28 months, 1-year survival rate was 40.74%, but the difference was not statistically significant P> 0.05). The 2-year survival rate was 43.46% in the study group, which was significantly higher than that in the control group (25.38%, P <0.05). The incidences of leukopenia and hair loss in the study group were 37.0% and 25.9% (P <0.05). The incidences of thrombocytopenia, hemoglobin decrease, vomiting, liver damage, renal dysfunction and skin rashes in the study group were 40.7% , 22.2%, 59.2%, 11.1%, 7.4% and 14.8% respectively, which were higher than those in the control group (33.3%, 18.5%, 55.5%, 14.8%, 11.1% and 7.4% The difference was not statistically significant (P> 0.05). Conclusion: Pemetrexed + cisplatin chemotherapy combined with concurrent chemoradiotherapy is effective in the treatment of locally advanced non-small cell lung cancer and has few side effects. It can be used as the first-line chemotherapy in advanced non-small cell lung cancer.
其他文献
<正> 一问:现已颁发哪些有关会计专业职务评聘工作的文件? 答:主要有以下几个文件: 1.中央职称改革工作领导小组(1986)职改字第55号文件转发的《会计专业职务试行条例》和《
GNSS-R已成为一种新兴的海洋遥感技术。它利用GNSS-R接收机同步接收导航卫星反射信号和直达信号,通过反演处理得到海面平均高度、有效波高、风速风向等参数。星载GNSS-R遥感
目的:比较分析单侧和双侧入路经皮穿刺椎体后凸成形术(PKP)治疗骨质疏松椎体压缩性骨折(OVCFS)的临床研究。方法:本文回顾性分析自2018年6月至2019年6月因OVCFS于成都中医药
<正> 中国中青年财务成本研究会最近成立。该会是由全国热心于财务、成本管理科学研究的中青年自愿结合而成的群众性学术团体,聘请许毅、杨纪琬、黄菊波、王振之、石成岳等专
<正>企业经营承包责任制中值得注意的一种不健康倾向,是承包人基于本身的经济利益,而不择手段地采取各种不正当的行为。它的特点是,目光短浅、急近利而无远谋,图目前的小利而
作为机器学习中的一个主要分支,强化学习从智能体和环境之间的交互数据中学习最优控制策略。通过计算目标函数对策略参数的导数一直是解决强化学习问题的主流方向,近年来基于
采用灰色预测法对某工程试验堤的实测沉降进行沉降预测,并经模型精度检验和与双曲线法、Asaoka法的预测结果进行对比,结果可信。
期刊
<正> 上海市会计专业高级职务评审委员会自1987年9月第一次会议至1988年9月第十一次会议,共受理了推荐评审高级会计师三百余人,其中,有267人获得通过符合高级会计师的任职条
介绍了预应力钢筒混凝土管的结构、性能和施工方法,通过永嘉县西向供水原水输送工程实际应用,说明在该地质条件下的施工工艺和方案,并取得良好的工程效果。